Literature DB >> 16484001

Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations.

Caglar Cakir1, Mine G Gulluoglu, Dilek Yilmazbayhan.   

Abstract

AIMS: The differential diagnosis of malignant mesothelioma (MM) from benign mesothelial lesions (BML) based on histopathological criteria is sometimes not satisfying and causes diagnostic problems for histopathologists. We aimed to investigate whether the immunohistochemically determined cell proliferation rate and telomerase activity, using Ki-67 and human telomerase reverse transcriptase (hTERT) immunohistochemistry, respectively, are useful in the differential diagnosis of MM from BML.
METHODS: Sixty-six cases of MM (33 epithelioid, 30 biphasic and 3 sarcomatoid) and 22 cases of BML (15 reactive mesothelial proliferations and 7 fibrous pleuritis/pericarditis) were included in this study. We evaluated the proliferative activity by Ki-67 and telomerase activity by hTERT immunohistochemistries for each case.
RESULTS: The mean value of the Ki-67 proliferation index (PI) in MMs was significantly higher than that of BMLs. Biphasic MMs have higher a Ki-67 PI than epithelioid and sarcomatoid types. Ki-67 immunohistochemistry has a sensitivity of 74%, specificity of 86% and positive predictive value of 94% in detecting MM. hTERT immunohistochemistry detected MM with sensitivity and specificity of 68%.
CONCLUSION: As a result, being cheap and simple methods, Ki-67 and hTERT immunohistochemistries can be used in differentiating malignant and benign mesothelial lesions in routine formalin-fixed, paraffin-embedded material.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484001     DOI: 10.1080/00313020500456017

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  Integrated nanosensors to determine levels and functional activity of human telomerase.

Authors:  J Manuel Perez; Jan Grimm; Lee Josephson; Ralph Weissleder
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

2.  Immunohistochemical profile of normal mesothelium and histiocytic/methothelial hyperplasia: a case report.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2011-08-14

3.  β-catenin expression in benign and malignant pleural disorders.

Authors:  Waseem Anani; Richard Bruggeman; Dani S Zander
Journal:  Int J Clin Exp Pathol       Date:  2011-10-30

4.  Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor.

Authors:  Gulden Diniz; Safiye Aktas; Aysen Turedi; Gunyuz Temir; Ragip Ortac; Canan Vergin
Journal:  Tumour Biol       Date:  2011-05-08

5.  The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.

Authors:  J E Nutt; A R A Razak; K O'Toole; F Black; A E Quinn; A H Calvert; E R Plummer; J Lunec
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.